Daniel Ritz

Years Active: 2019-2019
Publications (10 Years): 1

Idorsia Pharmaceuticals Ltd

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Idorsia Pharmaceuticals Ltd

Switzerland

Senior Group Leader :: Drug Discovery Biology, Microbial Sciences

Actelion Pharmaceuticals Ltd

Switzerland

Senior Group Leader :: Drug Discovery Biology, Anti-Infectives

Actelion Pharmaceuticals Ltd

Switzerland

Lab head :: Drug Discovery Biology, Anti- Infectives

Cubist Pharmaceuticals Inc

United States

Senior Research Scientist :: Drug Discovery

Harvard Medical School

United States

Research Fellow :: Microbiology and Molecular Genetics

Publications

Alain Scaiola, Marc Leibundgut, Daniel Boehringer, Patrick Caspers, Daniel Bur, Hans H Locher, Georg Rueedi, Daniel Ritz
Structural basis of translation inhibition by cadazolid, a novel quinoxolidinone antibiotic. Scientific reports 9 (1) (2019)

Daniel Ritz.css-eqlu8i{font-size:small;padding-left:4px;}